NCT05637996

Brief Summary

Selective motor control is defined as the ability to perform the movement in isolation without revealing movement in another joint, without mirror movements, without using a flexor or extensor pattern in the extremities during a desired movement in one joint. Evaluation of selective motor control is important to predict future functional status in adult stroke patients. The Fugl-Meyer Upper Extremity Motor Rating Scale is the basic test in the assessment of motor functions in stroke patients. However, this test is a complicated scale and it takes more than one hour to complete the rating of the patient; Physicians without experience cannot perform the test because it is difficult. This planned study aims to demonstrate the validity and reliability of Selective Control of the Upper Extremity Scale (SCUES) in the evaluation of selective motor control of upper extremity in stroke patients; thus, it aims to present SCUES to medical professionals as a practical clinical tool to be used in stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 24, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 25, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 6, 2022

Completed
Last Updated

December 6, 2022

Status Verified

November 1, 2022

Enrollment Period

8 months

First QC Date

November 25, 2022

Last Update Submit

November 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Selective Control of the Upper Extremity Scale (SCUES)

    The SCUES is a video-based assessment tool that evaluates selective movements of shoulder, elbow, forearm, wrist, and fingers bilaterally.The test is performed as follows. The child is seated at a table front of the camera. The examiner demonstrates the desired movements to the child, and then passively moves the joint to represent the desired movement. The child is then asked to perform the desired movement actively. The video camera is placed in front of the participant from frontal plane. Selective voluntary motor control (SVMC) is scored as normal SVMC (3 points), mildly diminished SVMC (2 points), moderately diminished SVMC (1 point), and no SVMC (0 points) for each joint. The degree of SVMC is determined by the presence of 4 characteristics (movement in joints other than target joint, mirror movements, trunk movements, observed movement less than passive range of motion).The score of each joint is summed up to a maximum of 15 points per limb.

    15 min

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with a diagnosis of hemiplegia as a result of ischemic or hemorrhagic stroke documented by cranial CT or MRI, followed for at least 6 months, aged between 18-75 years, with upper extremity involvement and their Brunnstrom upper extremity staging is in between1-6.

You may qualify if:

  • Being between the ages of 18-75
  • History of unilateral ischemic or hemorrhagic stroke documented by cranial CT or MRI
  • At least 6 months have passed since the stroke
  • Upper extremity involvement between Brunnstrom stages 1 and 6
  • To be voluntarily accepting the process

You may not qualify if:

  • Presence of additional diseases with progressive neurological deficit such as multiple sclerosis, amyotrophic lateral sclerosis
  • Having additional muscle disease
  • History of previous upper extremity surgery
  • Botulinum toxin for spasticity treatment in the last 3 months
  • Active localized or systemic infection
  • Presence of diagnosed lymphedema in the upper extremities
  • Having other neurological disorder affecting the upper extremity like brachial plexopathy etc.
  • History of malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatih Sultan Mehmet Training and Research Hospital

Istanbul, Atasehir, 34752, Turkey (Türkiye)

Location

Related Publications (3)

  • Wagner LV, Davids JR, Hardin JW. Selective Control of the Upper Extremity Scale: validation of a clinical assessment tool for children with hemiplegic cerebral palsy. Dev Med Child Neurol. 2016 Jun;58(6):612-7. doi: 10.1111/dmcn.12949. Epub 2015 Nov 3.

    PMID: 26526592BACKGROUND
  • Tuncdemir M, Karakaya J, Kerem-Gunel M. Reliability and Validity of the Turkish Version of the Selective Control of the Upper Extremity Scale in Children with Cerebral Palsy. Phys Occup Ther Pediatr. 2022;42(1):99-112. doi: 10.1080/01942638.2021.1928809. Epub 2021 May 24.

    PMID: 34030602BACKGROUND
  • Lieber J, Gartmann T, Keller JW, van Hedel HJA. Validity and reliability of the Selective Control of the Upper Extremity Scale in children with upper motor neuron lesions. Disabil Rehabil. 2022 Jul;44(14):3694-3700. doi: 10.1080/09638288.2021.1881171. Epub 2021 Feb 12.

    PMID: 33577357BACKGROUND

Related Links

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2022

First Posted

December 6, 2022

Study Start

February 1, 2022

Primary Completion

September 15, 2022

Study Completion

October 24, 2022

Last Updated

December 6, 2022

Record last verified: 2022-11

Locations